Clinical trials sponsored by Fujian Akeylink Biotechnology Co., Ltd.

Phase breakdown

Conditions studied

Recruiting trials led by Fujian Akeylink Biotechnology Co., Ltd.

• A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B
  NCT06263959 · Phase: Phase 2 · Ages: 35 Years to 65 Years · Sex: All (male and female) · 1 location
• Study of GST-HG131&141 Tablets Compared With Placebo in Patients With Chronic Hepatitis B
  NCT07709520 · Phase: Phase 2 · Ages: 35 Years to 65 Years · Sex: All (male and female) · 1 location
• To Evaluate the Efficacy, Safety and Population Pharmacokinetics of GST-HG141 in Patients With Chronic Hepatitis B (CHB) Who Have an Inadequate Response to Antiviral Drug Treatment
  NCT07090759 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is Fujian Akeylink Biotechnology Co., Ltd. recruiting for?

Fujian Akeylink Biotechnology Co., Ltd. is the lead sponsor of 3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.